• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Otolaryngology-Head & Neck Surgery

    Journal of Otolaryngology-Head & Neck Surgery

    JournalISSN 1916-0216eISSN 1916-0216中科院 医学 3区

    年发文量

    研究主题

    论文(1655)

    排序
    1NewDizziness and Balance-Related Symptom Burden and 12-Month Fall Risk in U.S. Adults Aged 20 to 69 Years
    Xing Lin MM, Wen Lv MM, Bo Shu MM, Huimin Cai MM, Heng Xiao MD, Shengnan Ye MD

    Importance: Falls are often viewed as a problem of older age, yet dizziness and balance-related symptoms are common in adulthood and may help identify adults with elevated fall burden. Objective: To examine associations of dizziness and balance-related symptom burden with 12-month fall outcomes in U.S. adults aged 20 to 69 years and whether objective balance impairment adds information beyond symptoms. Design: Cross-sectional study. Setting: National Health and Nutrition Examination Survey 2021 to 2023. Participants: The primary cohort included 6000 adults aged 20 to 69 years with complete symptom and outcome data. Extension analyses included participants with complete Modified Romberg Test data. Intervention or Exposures: Self-reported dizziness/balance-related symptoms in the past 12 months: vertigo, blurred vision with head movement, unsteadiness, and light-headedness/fainting. Secondary exposures were symptom count and objective balance impairment. Main Outcome Measures: Any fall, recurrent falls (≥3), frequent falls (≥5), and fall-related injury in the past 12 months. Survey-weighted quasi-Poisson regression estimated prevalence ratios (PRs) and 95% confidence intervals (CIs). Results: The weighted prevalence of any dizziness/balance-related symptom was 32.7%. After full adjustment, any symptom was associated with any fall (PR, 1.57; 95% CI, 1.40-1.75), recurrent falls (PR, 3.44; 95% CI, 2.81-4.21), frequent falls (PR, 5.09; 95% CI, 3.64-7.13), and fall-related injury (PR, 2.10; 95% CI, 1.66-2.65). Symptom count showed a dose-response relationship across outcomes. Compared with no symptoms, reporting 3 or more symptoms was associated with PRs of 1.97, 5.24, 8.19, and 3.10, respectively. Objective balance impairment alone showed weaker associations, whereas joint symptom-impairment phenotypes better stratified fall burden. Conclusions: Dizziness and balance-related symptom burden were strongly associated with multiple 12-month fall outcomes in U.S. adults aged 20 to 69 years. Objective balance impairment added limited complementary information beyond symptoms. Relevance: Symptom-based assessment may be a practical first step, with objective balance testing used selectively.

    2026
    引用
    AI阅读
    加入学术空间
    2NewDiagnostic Performance of BUU-Customized Whole-Exome Sequencing for Suspicious Thyroid Nodules: A Prospective Diagnostic Accuracy Study
    Narit Jianbunjongkit MD, Apinya Jusakul PhD, Kanchana Suksri PhD, Alisara Wongsuttilert MD, Nattawut Amornpinyokiat PhD, Watchareporn Teeramatwanich MD, Krongchai Kasemsrithanawat MD, Pattaravadee Srikoon PhD

    Importance: Suspicious thyroid nodules often prompt avoidable surgeries due to diagnostic uncertainty. Although commercial next-generation sequencing assays improve risk stratification, evidence for locally developed sequencing pipelines remains limited. Objective: To evaluate the diagnostic performance of Burapha University-customized whole-exome sequencing (BUU-WES) using preoperative ultrasound-guided core needle biopsy (CNB) specimens, with postsurgical histopathology as the reference standard. Design: Multicenter prospective diagnostic accuracy study. Setting: Four tertiary-care hospitals in Thailand. Participants: Adults (≥20 years) undergoing thyroid surgery for nodules suspicious on ultrasonography (American College of Radiology Thyroid Imaging Reporting and Data System 4-5) and/or cytology (Bethesda I-V). Intervention: DNA extracted from CNB specimens underwent BUU-WES; variants were interpreted using curated databases and published evidence. Main Outcome and Measures: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy with 95% confidence intervals (CIs). Results: Among 82 participants (82 index nodules), malignancy prevalence was 25.6% (21/82). BUU-WES demonstrated sensitivity of 57.1% (95% CI, 34.0%-78.2%), specificity of 86.9% (95% CI, 75.8%-94.2%), PPV of 60.0% (95% CI, 36.1%-80.9%), and NPV of 85.5% (95% CI, 74.2%-93.1%). In nodules ≥1 cm (n = 71), sensitivity increased to 83.3% (95% CI, 51.6%-97.9%), specificity 89.8% (79.2%-96.2%), with NPV 96.4% (95% CI, 87.5%-99.6%). In indeterminate cytology (Bethesda III/IV), BUU-WES showed moderate diagnostic performance, with sensitivity of 60% and specificity and NPV of 86.4%. The most frequently detected alterations involved BRAF , NRAS , and KRAS . Conclusions: BUU-WES primarily functions as a rule-in test due to its high specificity. Its most clinically relevant application is in indeterminate thyroid nodules (Bethesda III/IV), where it serves as an adjunctive tool for risk stratification. Within this subgroup, diagnostic performance is further optimized in nodules ≥1 cm, where the improved NPV suggests potential rule-out applicability in appropriately selected patients.

    2026
    引用
    AI阅读
    加入学术空间
    3NewTezepelumab in Canadian Adults with Severe Chronic Rhinosinusitis with Nasal Polyps: A Subgroup Analysis of the Phase 3 WAYPOINT Trial
    Martin Desrosiers MD, Marie-Noelle Corriveau MD, Remi Gagnon MD, Andrew Foster PhD, Emilie Millaire MD, Jason A. Ohayon MD, Jane Ran PharmD, Marc Tewfik MDCM, Andrew Thamboo MD, Leigh J. Sowerby MD

    Importance: Tezepelumab, a monoclonal antibody targeted against thymic stromal lymphopoietin, was recently approved in Canada for the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). Its effectiveness specifically in the Canadian setting has not been evaluated. Objective: To analyze the efficacy and safety of tezepelumab in Canadian patients enrolled in the WAYPOINT trial and contextualize the findings with respect to the Canadian healthcare environment. Design: Post hoc analysis of a multinational, parallel-group, randomized, placebo-controlled, Phase 3 trial. Participants: Forty-nine Canadian adult patients with severe uncontrolled CRSwNP. Setting: Subgroup of Canadian patients enrolled in the WAYPOINT trial. Intervention: Tezepelumab 210 mg (n = 25) or placebo (n = 24) administered subcutaneously every 4 weeks for 52 weeks. Main Outcome Measures: The co-primary endpoints were change from baseline to week 52 in endoscopic total nasal polyp score (NPS) and patient-reported bi-weekly nasal congestion score (NCS). Results: The Canadian cohort had higher numbers of patients with asthma and nonsteroidal anti-inflammatory drug-exacerbated respiratory disease than in the full study population. Objective and subjective signs and symptoms of CRSwNP were significantly improved with tezepelumab compared with placebo in the Canadian cohort, including both co-primary endpoints (least squares mean difference vs placebo [95% confidence interval]: total NPS, −2.53 [−3.33 to −1.73], P < .0001; mean NCS, −1.10 [−1.62 to −0.58], P < .0001) and all secondary efficacy endpoints in the overall population. The magnitude of clinical benefit was similar in the Canadian cohort versus the full study population, with less frequent use of rescue therapy (nasal polyp surgery and/or systemic corticosteroids) compared to placebo. The safety profile of tezepelumab was consistent in the Canadian cohort as in the full study population. There were no serious adverse events (AEs) or discontinuations due to AEs in the Canadian cohort. Conclusions: Tezepelumab is an effective and safe treatment for severe uncontrolled CRSwNP in a patient population that is reflective of the Canadian clinical landscape. Relevance: The multinational WAYPOINT trial findings are relevant to patients with CRSwNP routinely seen in Canadian clinical practice, supporting their applicability in the Canadian healthcare context. Trial Registry: WAYPOINT ClinicalTrials.gov number, NCT04851964.

    2026
    引用
    AI阅读
    加入学术空间
    4NewRadiological Predictors for Dysphagia Outcome in Patients Following Posterior Fossa Tumor Surgery
    Karsten Lachner MD, Jürgen Konczalla MD, Corinna Manß MSc, Elena Harborth MSc, Maximilian Rauch MD, Markus Czabanka MD, Elke Hattingen MD, Sriramya Lapa PhD

    Importance: Dysphagia is frequently observed in patients with posterior fossa tumor (PFT). Surgery can cause either deterioration of or improvement in preexisting dysphagia. In this context, imaging findings might help in predicting postsurgical dysphagic outcomes. Objective: To identify radiological predictors for worsening or improvement in presurgical dysphagia, and for any new onset of postsurgical dysphagia, by analyzing the presurgical brain magnetic resonance imaging (pMRI). Setting: Tertiary referral hospital. Participants: Patients undergoing neurosurgical treatment for PFT. Intervention: Flexible endoscopic evaluation of swallowing, before and after surgery. Main Outcome Measures: pMRI findings (presence of affection of cranial nerves V, VII, IX, X, and XII, ventrocaudal pontine compression, olivary compression, hydrocephalus) associated with postsurgical dysphagia outcomes. Dysphagia severity was rated according to the Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS). Results: Forty-three patients (60.5% female, 51.5 ± 15.6 years) with PFT-surgery were included. Presurgical dysphagia rate increased from 72.1% (n = 31), with a median FEDSS of 1 (IQR 2 range 1-5), to 79.1% (n = 34). In 46.5% (n = 20) of the cases deterioration of presurgical dysphagia was observed with a median of 1 (IQR 3, range 1-6), while 8 subjects showed a new onset of dysphagia. In 23.3% (n = 10) of the patients, an improvement in presurgical dysphagia was observed. In 2 cases, dysphagia severity decreased from severe to mild. pMRI did not show a significant association with postsurgical dysphagic outcome. Conclusions: Morphological characteristics of the brain tumor prior to surgery are not associated with dysphagia outcome. Besides the small sample size limiting statistical analysis, one may postulate that pMRI findings alone might not suffice to predict dysphagia outcome in patients after PFT-surgery. Relevance: Our study provides insights into possible characteristics of the tumor in relation to dysphagia outcome. Future studies warrant a larger cohort, analysis of intraoperative factors, and findings from postsurgical MRI, to fully understand dysphagia outcome after PFT-surgery.

    2026
    引用
    AI阅读
    加入学术空间
    5NewAltered Neural Pitch Encoding in Vestibular Schwannoma: Evidence from Frequency-Following Responses
    Laura Jacxsens,Lana Biot,Vincent Van Rompaey,Carles Escera,Marc J.W. Lammers

    Importance: Vestibular schwannomas (VSs) frequently cause hearing dysfunction, yet standard clinical assessments may not fully capture neural processing deficits. Objective: To determine whether unilateral VS impairs neural encoding of speech sounds, as measured by frequency-following responses (FFRs), beyond hearing loss alone. Design: Exploratory observational case-control study with both within-subject and matched between-subject comparisons. Setting: Tertiary referral center (Antwerp University Hospital, Belgium). Participants: Twenty-three adults (mean age 53.7 ± 9.8 years; 13 men) with untreated unilateral VS and sufficient residual hearing for FFR assessment were included. Patients with prior VS treatment, neurological disease, middle ear pathology, or profound hearing loss were excluded. VS ears were matched to a previous sensorineural hearing loss (SNHL) cohort by age, sex, and hearing thresholds. Intervention or Exposures: Magnetic resonance imaging-confirmed unilateral VS. Main Outcome Measures: FFR measures of neural encoding of voice pitch were evaluated, with pitch strength as the primary outcome. Additional exploratory FFR measures and formant encoding ( F 1 ) were analyzed. Auditory brainstem response (ABR) latencies and thresholds were also recorded. Results: Within subjects, VS-affected ears showed reduced pitch strength compared with contralateral ears for both the /a/ and /o/ stimulus sections (both P = .023). In the matched comparison with SNHL controls, pitch strength remained significantly reduced ( P = .049 for /a/, P = .043 for /o/), whereas other FFR measures did not differ significantly. ABR analysis showed prolonged wave V latency and interpeak latency I to V in VS-affected ears. Conclusions: VS is associated with reduced neural encoding of voice pitch, most consistently reflected by reduced FFR pitch strength even after accounting for hearing loss. Relevance: These findings suggest a selective vulnerability of temporal pitch coding in VS and support the clinical potential of the FFR as an adjunct measure when standard audiological tests do not fully capture patient-reported listening difficulties.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1655 篇论文

    高被引作者

    作者引用发文
    Hadi Seikaly213184
    S. Mark Taylor142072
    Jeffrey Richard Harris133146
    Jonathan Trites121059
    Rotenberg Brian W119534
    Kevin Fung112245
    Daniel O Connell110832
    Vincent Biron104935
    Michael P. Hier91743
    Richard Payne87844

    高产作者

    作者引用发文
    Hadi Seikaly213184
    S. Mark Taylor142072
    Jonathan Trites121059
    Jeffrey Richard Harris133146
    Kevin Fung112245
    Richard Payne87844
    Michael P. Hier91743
    Leigh J Sowerby82836
    Vincent Biron104935
    Rotenberg Brian W119534

    相关期刊

    Annals of Otology, Rhinology & Laryngology
    Otolaryngologia polska = The Polish otolaryngology
    International journal of otolaryngology
    International archives of otorhinolaryngology
    Laryngoscope investigative otolaryngology
    World journal of otorhinolaryngology - head and neck surgery
    Acta Otorhinolaryngologica Italica
    Clinical Otolaryngology
    Brazilian Journal of Otorhinolaryngology
    European Annals of Otorhinolaryngology, Head and Neck Diseases